Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (T1D) (R01)
| קרן | National Institute of Diabetes and Digestive and Kidney Diseases/NIH |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants |
| תאריך אחרון | 10/05/2018 |
| פקולטה | Engineering, Exact Sciences, Life Sciences, Medicine |
| תיאור | This grant encourages applications from institutions/organizations proposing original research addressing barriers that limit progress toward effective cell replacement therapies for type 1 diabetes (T1D). The purpose is to support research leading to the development and testing of novel and supportive technologies for the improvement of cell replacement interventions using novel biomaterials and devices for T1D treatment Funding: $500,000 per year Duration: 4 years
Research Authority due date: 27.3.18 LOI (encouraged) due date: 10.4.18 Full application due date: 10.5.18 |
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 18/02/2018 |
